Cassava Sciences Phase 3 Data
Health News

Cassava Sciences Phase 3 Data Falls Short in Alzheimer’s Study

Disappointing Results for Alzheimer’s Drug Simufilam Introduction: Cassava Sciences Phase 3 Data Cassava Sciences, Inc. recently announced the topline results […]